Genome-wide association study of HPV-associated cervical cancer in Japanese women

Journal of Medical Virology

Volumn 86, Issue 7, 2014, Pages 1153-1158

  Miura, Kiyonori ^a   Mishima, Hiroyuki ^a   Kinoshita, Akira ^a   Hayashida, Chisa ^a   Abe, Shuhei ^a   Tokunaga, Katsushi ^b   Masuzaki, Hideaki ^a   Yoshiura, Koh Ichiro ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

GWAS; Human papilloma virus; Susceptibility; Uterine cervical cancer

Indexed keywords

ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; JAPANESE (PEOPLE); MALE; PAPILLOMAVIRUS INFECTION; PERSISTENT INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA IN SITU; VIRAL CLEARANCE; WART VIRUS; COMPLICATION; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; ISOLATION AND PURIFICATION; JAPAN; PAPILLOMA VIRUS; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; JAPAN; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 84899959445     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23943     Document Type: Article

References (21)

1. Abe S, Miura K, Kinoshita A, Mishima H, Miura S, Yamasaki K, Hassegawa Y, Higashijima A, Jo O, Yoshida A, Yoshiura K, Masuzaki H. 2013. Copy number variation of the antimicrobial-gene, defensin beta 4, is associated with susceptibility to cervical cancer. J Hum Genet 58:250-253.
2. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J. 2011. Worldwide burden of cervical cancer in 2008. Ann Oncol 22:2675-2686.
3. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. 2007. GenABEL: An R library for genome-wide association analysis. Bioinformatics 23:1294-1296.
4. Castellsague X, Munoz N. 2003. Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20-28.
5. Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, Gustavsson I, Feuk L, Magnusson PK, McKay JD, Wilander E, Gyllensten U. 2013. Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst 105:624-633.
6. Ge D, Zhang K, Need AC, Martin O, Fellay J, Urban TJ, Telenti A, Goldstein DB. 2008. WGAViewer: Software for genomic annotation of whole genome association studies. Genome Res 18:640-643.
7. Habbous S, Pang V, Eng L, Xu W, Kurtz G, Liu FF, Mackay H, Amir E, Liu G. 2012. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: A systematic review and meta-analysis. Clin Cancer Res 18:6407-6415.
8. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423-428.
9. Li M-X, Jiang L, Ho S-L, Song Y-Q, Sham P-C. 2007. IGG: A tool to integrate GeneChips for genetic studies. Bioinformatics 23:3105-3107.
10. Li M-X, Jiang L, Kao PY-P, Sham P-C, Song Y-Q. 2009. IG G3: A tool to rapidly integrate large genotype datasets for whole-genome imputation and individual-level meta-analysis. Bioinformatics 25:1449-1450.
11. Matsumoto K, Maeda H, Oki A, Takatsuka N, Yasugi T, Furuta R, Hirata R, Mitsuhashi A, Fujii T, Hirai Y, Iwasaka T, Yaegashi N, Watanabe Y, Nagai Y, Kitagawa T, Yoshikawa H, for Japan HPV and Cervical Cancer (JHACC) Study Group. 2012. HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: A multicenter prospective cohort study. Int J Gynecol Cancer 22:471-478.
12. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. 1993. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 82:578-585.
13. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
15. Safaeian M, Hildesheim A, Gonzalez P, Yu K, Porras C, Li Q, Rodriguez AC, Sherman ME, Schiffman M, Wacholder S, Burk R, Herrero R, Burdette L, Chanock SJ, Wang SS. 2012. Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS ONE 7:e33619.
16. Shi Y, Li L, Hu Z, Li S, Wang S, Liu J, Wu C, He L, Zhou J, Li Z, Hu T, Chen Y, Jia Y, Wang S, Wu L, Cheng X, Yang Z, Yang R, Li X, Huang K, Zhang Q, Zhou H, Tang F, Chen Z, Shen J, Jiang J, Ding H, Xing H, Zhang S, Qu P, Song X, Lin Z, Deng D, Xi L, Lv W, Han X, Tao G, Yan L, Han Z, Li Z, Miao X, Pan S, Shen Y, Wang H, Liu D, Gong E, Li Z, Zhou L, Luan X, Wang C, Song Q, Wu S, Xu H, Shen J, Qiang F, Ma G, Liu L, Chen X, Liu J, Wu J, Shen Y, Wen Y, Chu M, Yu J, Hu X, Fan Y, He H, Jiang Y, Lei Z, Liu C, Chen J, Zhang Y, Yi C, Chen S, Li W, Wang D, Wang Z, Di W, Shen K, Lin D, Shen H, Feng Y, Xie X, Ma D. 2013. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet 45:918-922.
17. Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL. 2011. ATHENA (Addressing THE Need for Advanced HPV Diagnostics) HPV Study Group. High-risk human papillomavirus testing in women with ASC-US cytology: Results from the ATHENA HPV study. Am J Clin Pathol 135:468-475.
18. Wang M, Chu H, Wang S, Wang M, Wang W, Han S, Zhang Z. 2013. Genetic variant in APE1 gene promoter contributes to cervical cancer risk. Am J Obstet Gynecol 209:360.e1-367.e1.
19. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. 2001. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 357:1831-1836.
20. Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens C, Wright TL, ATHENA (Addressing The Need for Advanced HPV Diagnostics) Study Group. 2011. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. Am J Clin Pathol 136:578-586.
21. Zhao M, Qiu L, Tao N, Zhang L, Wu X, She Q, Zeng F, Wang Y, Wei S, Wu X. 2013. HLA DRB allele polymorphisms and risk of cervical cancer associated with human papillomavirus infection: A population study in China. Eur J Gynaecol Oncol 34:54-59.